Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Not effective COMMISSION DECISION of 21 June 2012 appointing members of the Committee for Orphan Medicinal Products (Text with EEA relevance)

Rozhodnutie č. 622/2012

Text language

Important dates

Declared: 21. júna 2012
Approved: 21. júna 2012
Effective from: 1. júla 2012
Effective until: 1. júla 2015

Documents and links

COMMISSION DECISION

of 21 June 2012

appointing members of the Committee for Orphan Medicinal Products

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to the Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products (1), and in particular Article 4(3) thereof,

Having regard to the recommendation of the European Medicines Agency of 1 February 2012,

Whereas:

(1)

The term of office of four members of the Committee for Orphan Medicinal Products, hereinafter ‘the Committee’, set up in accordance with Article 4 of Regulation (EC) No 141/2000, expires on 30 June 2012. One member of the Committee whose term of office expires was appointed by the Commission on the basis of a recommendation from the European Medicines Agency. Three other members whose term of office expires were appointed by the Commission to represent patients' organisations. It is necessary, therefore, to appoint four members to the Committee.

(2)

The European Medicines Agency has recommended one person for nomination.

(3)

The members of the Committee should be appointed for a period of three years starting on 1 July 2012,

HAS DECIDED AS FOLLOWS:

Article 1

The following are hereby reappointed members of the Committee to represent patients’ organisations for a term of three years, from 1 July 2012:

 

Ms Lesley Claire GREENE,

 

Ms Birthe BYSKOV HOLM,

 

Dr Marie Pauline EVERS.

Article 2

On the recommendation of the European Medicines Agency, the following is hereby appointed member of the Committee for a term of three years, from 1 July 2012:

Dr Catherine MORAITI.

Done at Brussels, 21 June 2012.

For the Commission

John DALLI

Member of the Commission

Poznámky